Rechallenge Dosing
Rechallenge Dosing is a dose scheduling strategy in clinical pharmacology wherein a therapeutic agent is reintroduced to a patient after prior discontinuation, typically to assess the recurrence or resolution of treatment effects or adverse events.
7
Publications
277
Citations
59
Authors
38
Institutions
Publications per year
2017–2026
4
Parents
7
Gifford Leoung, James Stanford, M Giordano et al. · The Journal of Infectious Diseases · 2001 · 108 citations · Full text
Rechallenge with lamotrigine after initial rash
Simon Tavernor, Ian Chi Kei Wong, Richard Newton et al. · Seizure · 1995 · 64 citations · Full text
Davide Ciardiello, Vincenzo Famiglietti, Stefania Napolitano et al. · Clinical Colorectal Cancer · 2022 · 25 citations
Medicine, Oncology, Pharmacology +16
Erika Martinelli, Giulia Martini, Teresa Troiani et al. · Annals of Oncology · 2020 · 23 citations
Medicine, Oncology, Pharmacology +12
1–5 of 7
59
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 59
38
Azienda Ospedaliera Universitaria Pisana
Pisa, Italy
2 h-index
2 publications
48 citations

Casa Sollievo della Sofferenza
San Giovanni Rotondo, Italy
2 h-index
3 publications
73 citations
Aizawa Hospital
Matsumoto, Japan
2 h-index
2 publications
36 citations

University of Campania "Luigi Vanvitelli"
Caserta, Italy
2 h-index
19 publications
453 citations
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy
2 h-index
2 publications
48 citations
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Naples, Italy
2 h-index
4 publications
94 citations
Campus Bio Medico University Hospital
Rome, Italy
1 h-index
1 publications
23 citations
AstraZeneca (United Kingdom)
Cambridge, United Kingdom
1 h-index
1 publications
64 citations
1–8 of 38
3 publications · 59 citations
3
h-index
JID · 1 publications · 108 citations
1
h-index
1 publications · 21 citations
1
h-index
1 publications · 64 citations
1
h-index
1 publications · 25 citations
1
h-index
1–5